A meta-analysis of 16 controlled animal studies found that stem cell-based interventions improved mechanical strength, bone volume fraction and histological integration after ACL reconstruction, with ...

A research team in South Korea has successfully developed a novel technology that combines nanoparticles with stem cells to significantly improve 3D bone tissue regeneration. This advancement marks a ...

Shanghai, China--(Newsfile Corp. - September 9, 2026) - Frost & Sullivan officially unveils the 2026 Global Stem Cell Industry Development Blue Book, providing an in-depth analysis of the global stem ...

Researchers in Japan have successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse embryonic fibroblasts without using stem cell technology. The AT2-like cells ...

ASD is a neurodevelopmental condition that affects roughly 61.8 million people globally. Credit: Pixel-Shot / Shutterstock.com. · Pharmaceutical Technology · Pixel-Shot / Shutterstock.com. Biostar ...

When stem cells are injected into thick tissues, they often clump together and die from lack of oxygen or nutrients, making it almost impossible to use them for thick, highly vascularized tissues like ...

An interdisciplinary team of scientists has developed a technology to decode immune cell communication. By measuring interactions between cells, the method offers insights into how the human body ...

Recent advancements in stem cell therapy are paving the way for potential breakthroughs in reversing hearing loss. This innovative approach is gaining traction in the treatment of hearing disorders, ...

The global stem cell therapy market is entering an era of unprecedented growth and innovation. Valued at $5.13 billion in 2024, the U.S. stem cell market alone is projected to reach $15.79 billion by ...

This collaborative educational initiative will provide researchers, students, and technicians with practical guidance on how to apply the ISSCR Standards to responsibly use human pluripotent and ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Garuda Therapeutics (Garuda), a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced a $62 million Series B financing ...